Transforming growth factor-β and prostate cancer
✍ Scribed by M. S. Steiner
- Publisher
- Springer-Verlag
- Year
- 1995
- Tongue
- English
- Weight
- 991 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
✦ Synopsis
This review focuses on the possible role of transforming growth factor-~3 isoforms 1-3 (TGF~3) in prostate cancer. TGF~ 1 appears to inhibit the cellular proliferation of normal prostate cells. Surprisingly, TGF[31 is overexpressed in prostate cancer. To help explain this apparent paradox, it has been revealed that with tumor progression, prostate cancer cells acquire reduced sensitivity to the growth-inhibitory effects of TGF~I. Aberrations of the TGF~31 signaling pathway at the prereceptor, receptor, or postreceptor level may lead to prostate cancer cell resistance to TGF~I growth inhibition. Indirectly, elevated levels of TGF~31 may induce host effects that may be beneficial to prostate tumor growth by suppressing the immune system, promoting angiogenesis and extracellular matrix formation, and enhancing metastatic potential. Consequently, TGF~ 1 appears to be important in prostate carcinogenesis and tumorigenicity. TGF~32 and TGF~33 are only briefly presented as very little is known about their role in prostate cancer.
📜 SIMILAR VOLUMES
Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi
Using the mouse prostate reconstitution (MPR) model system, under conditions where the ras and myc oncogenes are introduced via a recombinant retrovirus into both the mesenchymal and epithelial compartments of the urogenital sinus, poorly differentiated prostate cancer is produced with high frequenc
## Abstract Transforming growth factor‐β (TGF‐β) family members are polypeptides with dual tumor suppressive and oncogenic effects. They signal through serine/threonine kinase receptor complexes, which phosphorylate cytoplasmic mediators, the Smads. Upon phosphorylation, Smads translocate to the nu